ASHBY: Accelerated Super-Hypofractionated Breast Brachytherapy — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

ASHBY: Accelerated Super-Hypofractionated Breast Brachytherapy — Stella

Home/Breast Cancer/

View on ClinicalTrials.gov

Recruiting

Back to Breast Cancer trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

United States

Virginia Commonwealth University, Richmond, Virginia

Key details

Phase

Safety & dosing

Sponsor

Virginia Commonwealth University

Enrollment target

~170 participants

Started

December 2023

Primary completion

January 2031

Age range

45 Years – 79 Years

Sex

Female only

Last updated November 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.